On January 4, 2022 Johnson & Johnson (NYSE: JNJ) reported that its Board of Directors has declared a cash dividend for the first quarter of 2022 of $1.06 per share on the company’s common stock (Press release, Johnson & Johnson, JAN 4, 2022, View Source;johnson-announces-quarterly-dividend-for-first-quarter-2022-301452880.html [SID1234598147]). The dividend is payable on March 8, 2022 to shareholders of record at the close of business on February 22, 2022. The ex-dividend date is February 18, 2022.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!